| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.137 | 29.534 | 32.142 | 32.974 | 32.204 | 22.275 | 31.077 | 31.271 | 29.277 | 20.256 |
| Total Income - EUR | 25.137 | 29.534 | 32.142 | 32.974 | 32.204 | 22.275 | 31.368 | 31.271 | 29.277 | 20.258 |
| Total Expenses - EUR | 9.668 | 5.469 | 5.183 | 7.656 | 1.135 | 3.718 | 10.680 | 12.746 | 18.396 | 13.163 |
| Gross Profit/Loss - EUR | 15.469 | 24.065 | 26.959 | 25.317 | 31.069 | 18.557 | 20.688 | 18.525 | 10.880 | 7.095 |
| Net Profit/Loss - EUR | 12.581 | 23.179 | 25.995 | 24.328 | 30.103 | 17.891 | 19.806 | 17.587 | 10.587 | 6.195 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Sigurmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 707 | 1.080 | 704 | 84 | 0 |
| Current Assets | 22.601 | 30.783 | 33.212 | 24.926 | 30.708 | 47.278 | 45.034 | 37.487 | 36.416 | 42.348 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 157 | 1.972 | 2.156 | 2.290 | 2.490 | 2.934 | 1.329 | 15.009 | 1.765 | 2.735 |
| Cash | 12.320 | 18.791 | 21.205 | 12.966 | 18.735 | 35.041 | 34.608 | 13.354 | 25.553 | 30.567 |
| Shareholders Funds | 11.172 | 23.233 | 26.047 | 24.380 | 30.154 | 17.940 | 19.854 | 17.635 | 14.839 | 20.951 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.429 | 7.550 | 7.165 | 546 | 555 | 30.045 | 26.260 | 20.556 | 21.661 | 21.397 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sigurmed S.r.l.